Chlabicz Małgorzata, Chlabicz Sławomir, Marcinowicz Ludmiła, Rogowska-Szadkowska Dorota, Pytel-Krolczuk Barbara, Leszczyńska Katarzyna
Przegl Epidemiol. 2014;68(3):435-41, 543-7.
The goal of this study was to evaluate the quantity and pattern of outpatient antibiotic use in Poland between 2004 and 2008 and to determine the trends in prescribing practice. To investigate the oral and parenteral outpatient antibiotic use in Poland.
Data concerning outpatient use of systemic antibiotics between 2004 and 2008 were obtained from Polish National Health Fund databases expressed as the number of defined daily doses (DDD) per 1000 inhabitants per day (DID) according to the international Anatomical Therapeutic Chemical ATC classification system of the World Health Organization (WHO, version 2009).
Total outpatient antibiotic use in Poland varied from the lowest 17.88DID in 2004 to the highest 21.39DID in 2007. Penicillins (J01C) represented the most frequently prescribed antibiotics constituting more than 50% of the total outpatient antibiotic use. The other most popular groups of antibiotics were tetracyclines (J01A), macrolides (J01F). On the fourth and fifth position were cephalosporins (J01D) and quinolones (J01M), respectively. The parenteral antibiotic use did not exceed 1% of the total outpatient antibiotics prescribed with cefuroxime being the most frequently prescribed drug.
Total outpatient use of antibiotics in Poland in 2004-2008 was comparable to the median European level. The consumption of all antibiotics slightly increased from 2004 to 2007, and decreased in 2008. The most often prescribed antibiotics were penicillins, mainly amoxicillin and amoxicillin with enzyme inhibitor. During the study period the use of the older (narrow-spectrum) antibiotics decreased in favour of the newer (broad-spectrum) antibiotics. The results suggest the discrepancy between national recommendations and choice of antibiotics by physicians.
本研究的目的是评估2004年至2008年波兰门诊抗生素的使用量和模式,并确定处方实践的趋势。调查波兰门诊口服和注射用抗生素的使用情况。
2004年至2008年期间门诊全身用抗生素的数据来自波兰国家卫生基金数据库,根据世界卫生组织(WHO,2009年版)的国际解剖治疗化学(ATC)分类系统,以每1000居民每天的限定日剂量(DDD)数(DID)表示。
波兰门诊抗生素的总使用量从2004年最低的17.88DID到2007年最高的21.39DID不等。青霉素(J01C)是最常处方的抗生素,占门诊抗生素总使用量的50%以上。其他最常用的抗生素类别是四环素(J01A)、大环内酯类(J01F)。排在第四和第五位的分别是头孢菌素(J01D)和喹诺酮类(J01M)。注射用抗生素的使用量不超过门诊处方抗生素总量的1%,其中头孢呋辛是最常处方的药物。
2004 - 2008年波兰门诊抗生素的总使用量与欧洲中位数水平相当。2004年至2007年所有抗生素的消费量略有增加,2008年有所下降。最常处方的抗生素是青霉素,主要是阿莫西林和阿莫西林与酶抑制剂的组合。在研究期间,旧的(窄谱)抗生素的使用减少,而新的(广谱)抗生素更受青睐。结果表明国家建议与医生选择抗生素之间存在差异。